Viking Global Opportunities Illiquid Investments Sub-Master LP, 10% Owner at BridgeBio Pharma, Inc. (BBIO), sold 6,131,232 shares at $34.90 ($214.0M) on 2025-01-31, disclosed to the SEC on 2025-01-31.
Open-market sale of $214.0M BBIO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.90 | 3,065,616 | $107.0M | 50.0% |
| 2 | $34.90 | 3,065,616 | $107.0M | 50.0% |
| Total | $34.90 avg | 6,131,232 | $214.0M | 100% |
| Filing → |
| AMLX | SELL | 2022-09-09 | $83.4M | — | Filing → |
| AMLX | BUY | 2022-01-13 | $43.7M | — | Filing → |
| RLYB | BUY | 2021-08-02 | $10.5M | — | Filing → |